Preferred Name |
Pyrazofurin |
|
Synonyms |
|
|
Definitions |
A nucleoside analog. Pyrazofurin potently inhibits orotidine 5'-monophosphate (OMP) decarboxylase, thereby interfering with de novo synthesis of uridine nucleotides and resulting in cytotoxicity. This agent also causes a rapid depletion of the pyrimidine deoxynucleotide pool, thereby inhibiting DNA synthesis and cell replication. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C1208 |
|
CAS_Registry |
30868-30-5 |
|
Chemical_Formula |
C9H13N3O6 |
|
code |
C1208 |
|
Contributing_Source |
FDA |
|
definition |
A nucleoside analog. Pyrazofurin potently inhibits orotidine 5'-monophosphate (OMP) decarboxylase, thereby interfering with de novo synthesis of uridine nucleotides and resulting in cytotoxicity. This agent also causes a rapid depletion of the pyrimidine deoxynucleotide pool, thereby inhibiting DNA synthesis and cell replication. (NCI04) |
|
FDA_UNII_Code |
4B15044GQZ |
|
in_subset | ||
label |
Pyrazofurin |
|
Legacy Concept Name |
Pyrazofurin |
|
NCI_Drug_Dictionary_ID |
39575 |
|
NSC Number |
143095 |
|
PDQ_Closed_Trial_Search_ID |
39575 |
|
PDQ_Open_Trial_Search_ID |
39575 |
|
Preferred_Name |
Pyrazofurin |
|
prefixIRI |
NCIT:C1208 |
|
prefLabel |
Pyrazofurin |
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide Antibiotic |
|
UMLS_CUI |
C0072661 |
|
subClassOf |